| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $270.6M | — |
| R&D Expense | $97.9M | +69.0% |
| SG&A Expense | $323.1M | +102.9% |
| Operating Income | -$231.8M | -28.9% |
| Pre-tax Income | -$238.3M | -27.3% |
| Income Tax | $960K | — |
| Net Income | -$239.2M | -27.8% |
| EPS (Basic) | -$5.27 | -14.6% |
| EPS (Diluted) | -$5.27 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $386.2M | +92.3% |
| Accounts Receivable | $94.8M | +151.5% |
| Inventory | $15.1M | +250.4% |
| Current Assets | $504.3M | +105.3% |
| Total Assets | $588.2M | +77.5% |
| Current Liabilities | $138.9M | +43.8% |
| Long-term Debt | $178.1M | +88.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$145.1M | -24.5% |
| Capital Expenditures | $582K | -17.1% |
| Investing Cash Flow | -$582K | +98.9% |
| Financing Cash Flow | $331.0M | +16.3% |
| Free Cash Flow | -$145.7M | -24.3% |
| -14.6% |
| Total Liabilities |
| $397.3M |
| +79.0% |
| Stockholders' Equity | $191.0M | +74.3% |